Epikast
Brooklyn, US · Founded 2022 · Delaware corporation · 2 known investors
Epikast provides medically trained talent and AI-driven engagement tools to biopharma and healthcare organizations for communicating with healthcare professionals and patients across the US and Europe. The company combines peer-to-peer engagement models, medical expertise, and proprietary AI insights to reduce costs and improve stakeholder outreach.
Founders & leadership
EV
Evangelos VergetisNamed on SEC filing
Board
ON

BP
Brad ProsekBoard director
SP
Stelios PapadopoulosBoard director
DK
Daphne KarydasBoard director
AT
Alexandros TzoukasBoard director
DP
Dimitrios PapalexopoulosBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$5.7M disclosed across 2 rounds · 2023–2026
▶$700KraisedFeb 2026 · 2 investors · Other Health CareRule 506(b)
▶$700KraisedFeb 2026 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brad ProsekDirector
- Evangelos VergetisExecutive Officer, Director
- Oleg NodelmanDirector
- Stelios PapadopoulosDirector
- Daphne KarydasDirector
- Alexandros TzoukasDirector
- Dimitrios PapalexopoulosDirector
- Offering amount
- $2.2M
- Amount sold
- $700K
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$5MraisedFeb 2023 · 2 investors · Other Health CareRule 506(b)
▶$5MraisedFeb 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Evangelos VergetisExecutive Officer, Director
- Stelios PapadopoulosDirector
- Offering amount
- $10M
- Amount sold
- $5M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Epikast do?
- Epikast provides medically trained talent and AI-driven engagement tools to biopharma and healthcare organizations for communicating with healthcare professionals and patients across the US and Europe. The company combines peer-to-peer engagement models, medical expertise, and proprietary AI insights to reduce costs and improve stakeholder outreach.
- Who are Epikast's investors?
- Epikast's investors include EcoR1 Capital, Vedanta Capital.
- How much funding has Epikast raised?
- Epikast has disclosed $5.7M raised across 2 rounds.
- Where is Epikast headquartered?
- Epikast is headquartered in Brooklyn, US.